A proposal for an out-of-range glycemic population health safety measure for older adults with diabetes

Diabetes Care

Volumn 40, Issue 4, 2017, Pages 518-525

  Pogach, Leonard ^a   Tseng, Chin Lin ^a   Soroka, Orysya ^a   Maney, Miriam ^a   Aron, David ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; HEMOGLOBIN A1C; INCRETIN; INSULIN; MEGLITINIDE; SULFONYLUREA; ANTIDIABETIC AGENT; CREATININE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; METFORMIN; SULFONYLUREA DERIVATIVE;

AGE; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRESCRIPTION; RISK ASSESSMENT; RISK REDUCTION; TOTAL QUALITY MANAGEMENT; BLOOD; COMORBIDITY; GLUCOSE BLOOD LEVEL; METABOLISM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; COMORBIDITY; CREATININE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 85019634205     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0953     Document Type: Conference Paper

References (40)

1. Centers for Disease Control and Prevention. National diabetes statistics report [Internet], 2014. Available from http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport .html. Accessed 18 September 2016
2. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012;35: 2650-2664
3. Inzucchi SE, Bergenstal RM, Buse JB, et al.; American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycemia in type 2 diabetes: a patientcentered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379
4. Department of Veterans Affairs/Department of Defense. Management of diabetes mellitus (DM): guideline summary [Internet], 2010. Available from http://www.healthquality.va.gov/guidelines/CD/diabetes/DM2010-SUM-v4.pdf. Accessed 10 August 2016
5. AGS Choosing Wisely Workgroup. American Geriatrics Society identifies five things that healthcare providers and patients should question. J Am Geriatr Soc 2014;62:950-960
6. Department of Health and Human Services. National action plan for adverse drug event prevention: diabetes agents [Internet], 2014. Available from http://www.health.gov/hcq/pdfs/ADE-Action-Plan-Diabetes-Agents.pdf. Accessed 18 September 2016
7. Pogach L, Aron D. Balancing hypoglycemia and glycemic control: a public health approach for insulin safety. JAMA 2010;303:2076-2077
8. Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014; 174:1116-1124
9. Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-686
10. NationalQuality Forum.National quality forumendorsedmeasures for endocrine conditions, 2013-2015: final report. Available from http://www.qualityforum.org/Publications/2015/11/NQF-Endorsed-Measures-for-Endocrine-Conditions-Final-Report.aspx. Accessed 10 August 2016
11. Aron D, Pogach L. One size does not fit all: a continuous measure for glycemic control in diabetes: the need for a new approach to assessing glycemic control. Jt Comm J Qual Improv 2007;33: 636-643
12. Pogach L, Aron D. The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure. Arch Intern Med 2012;172:1510-1512
13. Aron DC. No "black swan": unintended but not unanticipated consequences of diabetes performance measurement. Jt Comm J Qual Patient Saf 2013;39:106-108
14. American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetesd2016. Diabetes Care 2016;39(Suppl. 1):S52-S59
15. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149
16. National Institute of Diabetes and Digestive and Kidney Diseases. Comparing tests for diabetes and prediabetes: a quick reference guide [Internet], 2014. Available from https://www.niddk.nih.gov/health-information/health-topics/diagnostic-tests/comparing-tests-diabetesprediabetes/Documents/Comparing-Tests-for-DM-508.pdf. Accessed 18 September 2016
17. Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1-e47
18. Tseng CL, Soroka O, Maney M, et al. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med 2014; 174:259-268
19. Pogach LM, Tiwari A, Maney M, Rajan M, Miller DR, Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? Am J Manag Care 2007;13:133-140
20. Centers for Medicare & Medicaid Services. Quality measures [Internet], 2016. Available from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/index.html?redirect=/QUALITYMEASURES/. Accessed 18 September 2016
21. Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
22. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
23. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes inpatients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
24. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med 2015;175:356-362
25. Miller ME, Bonds DE, Gerstein HC, et al.; ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340:b5444
26. Punthakee Z, Miller ME, Launer LJ, et al.; ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35:787-793
27. Pathak RD, Schroeder EB, Seaquist ER, et al.; SUPREME-DMStudy Group. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:33-370
28. Berkowitz SA, Karter AJ, Lyles CR, et al. Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE). J Health Care Poor Underserved 2014;25:478-490
29. Sarkar U, Karter AJ, Liu JY, Moffet HH, Adler NE, Schillinger D. Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med 2010;25:962-968
30. Seligman HK, Bolger AF, Guzman D, L ópez A, Bibbins-Domingo K. Exhaustion of food budgets atmonth's end and hospital admissions for hypoglycemia. Health Aff (Millwood) 2014;33:116-123
31. National Quality Forum. Risk adjustment for socioeconomic status or other sociodemographic factors [Internet], 2014. Available from http://www.qualityforum.org/Publications/2014/08/Risk-Adjustment-for-Socioeconomic-Status-or-Other-Sociodemographic-Factors.aspx. Accessed 18 September 2016
32. Cahn A, Raz I, Kleinman Y, et al. Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists. Diabetes Care 2015; 38:2293-2300
33. Purnell TS, Joy S, Little E, Bridges JF, Maruthur N. Patient preferences for noninsulin diabetes medications: a systematic review. Diabetes Care 2014;37:2055-2062
34. Chin MH, Drum ML, Jin L, Shook ME, Huang ES, Meltzer DO. Variation in treatment preferences and care goals among older patients with diabetes and their physicians. Med Care 2008; 46:275-286
35. U.S. Food and Drug Administration. FDA drug safety communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function [Internet]. Available from http://www.fda.gov/Drugs/DrugSafety/ucm493244 .htm. Accessed 18 September 2016
36. American Association of Clinical Endocrinologists; American College of Endocrinology. AACE/ACE comprehensive type 2 diabetes management algorithm2016 [Internet], 2016. Available from https://www.aace.com/publications/algorithm. Accessed 10 August 2016
37. Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA 2016;315:1034-1045
38. Fenton SH, Benigni MS. Projected impact of the ICD-10-CM/PCS conversion on longitudinal data and the Joint Commission Core Measures. Perspect Health Inf Manag 2014;11:1g. Available from http://perspectives.ahima.org/projected-impact-of-the-icd-10-cmpcs-conversionon- longitudinal-data-and-the-joint-commissioncore- measures/#.VxzO6jHkoXg. Accessed 18 September 2016
39. Department of Health and Human Services; Centers for Medicare & Medicaid Services. 42 CFR Parts 414 and 495: Medicare program; Merit-based Incentive Payment System (MIPS) and Alternative Payment Model (APM) incentive under the physician fee schedule, and criteria for physician-focused payment models [proposed rule]. 81 Fed Reg 28162 (9 May 2016). Available from https://www.gpo.gov/fdsys/pkg/FR-2016-05-09/pdf/2016-10032.pdf. Accessed 18 September 2016
40. Sarosi GA. The tyranny of guidelines. Ann Intern Med 2015;163:562-563